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Previewsdecreased ability to survive acute hema-
topoietic stress. Perhaps the evolutionary
pressure on murine NLRP1, shown both
by its apparent divergence into three
homologs and the existence of multiple
forms of NLRP1b, is an example of the
intricate balance between the beneficial
and harmful functions of NLRP1. The final
answermight comewith the elucidation of
the exact ligands or cellular conditions
that activate NLRP1 in mice and humans.
This, together with the work by Masters
et al. (2012), should begin to clarify the
various roles of NLRP1 in host defense
and homeostasis.952 Immunity 37, December 14, 2012 ª2012REFERENCES
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Interleukin-22 (IL-22) enhancesmucosal barrier function and is important in antimicrobial host defense. In this
issue of Immunity, Basu et al. (2012) reveal that Th22 cells are the critical adaptive source of IL-22 during
late-phase infection by Citrobacter rodentium.Interleukin-22 (IL-22) belongs to the IL-10
cytokine family and is expressed by
innate and adaptive lymphocytes
(Ouyang et al., 2011). IL-22 binds to a
heterodimeric receptor consisting of IL-
22R1 and IL-10R2. IL-22R1, the ligand
binding subunit, is expressed by nonhe-
matopoietic cells such as the epithelial
cells of the gastrointestinal tract and
skin. Therefore, IL-22 functions as a
signaling mediator that can connect
lymphocytes and epithelial cells. IL-22-
IL-22R signaling in epithelial cells results
in expression of genes involved in
antimicrobial host defense including
S100 proteins, defensins, Lipocalin 2,
and RegIII-family proteins. IL-22 also
induces inflammatory molecules such
as chemokines and cytokines including
IL-6. In addition, IL-22 has an important
function in tissue repair via induction of
epithelial cell proliferation and survival.
By inducing such genes and by enhanc-ing epithelial barrier function, IL-22
plays an important role in promoting
resistance to extracellular pathogens,
particularly to Gram-negative pathogens.
Indeed, IL-22 signaling is essential for
protective immunity to extracellular
Klebsiella pneumoniae in the lung and
Citrobacter rodentium in the intestine
(Aujla et al., 2008; Sonnenberg et al.,
2011; Zheng et al., 2008). IL-22 signaling
is also required to prevent systemic
dissemination of the Alcaligenes bacteria
species, which are normally commensal
and constitutively reside within the
Peyer’s patches (Sonnenberg et al.,
2012). In addition, IL-22 prevents tissue
destruction in several mouse models.
In a ConcanavalinA-induced hepatitis
model, IL-22 protects from liver injury
by enhancing the growth and survival
of hepatocytes. In the intestine, IL-22
prevents tissue destruction in dextran
sodium sulfate-mediated colitis and ina mouse model of graft versus host
disease. In contrast, dysregulated IL-
22-IL-22R signaling can promote patho-
logical inflammatory responses in the
skin and intestine in mouse models, and
the concentration of IL-22 is increased
in a variety of human diseases including
psoriasis, rheumatoid arthritis, and
inflammatory bowel diseases. Further-
more, excessive and aberrant IL-22
signaling results in colon cancer develop-
ment, as exemplified by mice lacking
IL-22-binding protein (IL-22BP), a soluble
high-affinity decoy receptor for IL-22
(Huber et al., 2012).
Innate lymphoid cells (ILCs) are one of
the major sources of IL-22 (Sonnenberg
and Artis, 2012). IL-22-producing ILCs
include CD4+ lymphoid-tissue inducer-
like cells and NKp46+ natural killer-like
cells and are now referred to as group
3 ILCs (ILC3s) (Sonnenberg and Artis,













IL-23- and ILC-dependent 
early phase




Figure 1. Th22 Cells Play a Critical Role in the Late-Phase Response to an Intestinal
Pathogen
During the early phase of Citrobacter rodentium infection, IL-23-mediated IL-22 production by group 3
innate lymphoid cells (ILC3s) plays a critical role. In the later phase, IL-6-mediated differentiation and/or
accumulation of Th22 cells and their production of IL-22 critically contribute to the eradication of the path-
ogen. IL-23 can induce inflammation, leading to IL-6 production by antigen-presenting cells, which then
further contributes to the induction of Th22 cells. TGF-b has reciprocal effects on the differentiation of
Th17 cells (induction) and Th22 cells (suppression), and T-bet and AhR act as transcription factors
required for the production of IL-22 in Th22 cells.
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Previewsmucosal tissues where they are engaged
in a continuous cross talk with epithelial
cells. All IL-22+ ILC3 subsets express
the transcription factor RORgt, which
is required for their development and
expression of the IL-23R; signaling
through this receptor is sufficient to
induce IL-22 production by ILC3. IL-23-
mediated IL-22 production by ILC3s
plays an essential role in the early
phases of immunity in response to
enteric pathogens such as C. rodentium,
which is a close relative of entero-
pathogenic E. coli and forms attaching
and effacing lesions on the apical sur-
faces of enterocytes. Mice deficient
for Il23a or Il22 are highly susceptible
to C. rodentium and die within the first
2 weeks of infection. Interestingly,
although Rag2/mice show comparable
levels of IL-22 production during the
early phase of infection, Rag2/ mice
gradually exhibit weight loss and eventu-
ally becomemoribund by around 4 weeks
(Zheng et al., 2008), suggesting that
adaptive cells also play important protec-
tive role in the late phase of C. rodentiuminfection. In spite of recent advances, the
responsible cellular source and molecular
mechanisms underlying IL-22 production
by adaptive immune cells still remain
unclear.
In this issue of Immunity, Basu et al.
(2012) have used extensive analyses
of various mutant mice and an in vitro
culture system to highlight the role of
Th22 cells in the host response against
C. rodentium (Figure 1). The authors first
observed that Il23a/ mice survived
when challenged with low-dose infection.
However, when treated with IL-22 block-
ing antibody, the Il23a/ mice rapidly
succumbed to the low-dose infection
with C. rodentium. This effect of anti-
IL-22 was observed even when it was
injected after the peak of the innate
immune response. Therefore, IL-23-
independent IL-22 production, presum-
ably by non-ILCs, plays an important
role in the protection of mice against
C. rodentium. Moreover, there was
a marked accumulation of IL-22+IL-
17CD4+ T cells (referred to as Th22 cells)
in the colon of wild-type mice during theImmunity 37, Dlate phase of infection. Th22 cells were
more frequent than IL-22+IL-17+ or IL-
22IL-17+ cells (namely, Th17 cells) at
any time point. These results suggest
the important contribution of Th22 cells
to the IL-23-independent IL-22 produc-
tion. The authors next identified IL-6 as
a critical cytokine for the induction of
Th22 cell differentiation. Il6/ mice inoc-
ulated with C. rodentium phenocopied
the Il22/ mice, displaying increased
epithelial injury and ulceration in the
colon, albeit with delayed kinetics, and
more focal lesions compared to the
Il23a/ mice. By in vitro experiments
with naive CD4+ T cells, the authors
showed that IL-6 could directly act on
T cells and efficiently induce the differen-
tiation of Th22 cells from naive pre-
cursors. IL-23 acted synergistically with
IL-6 by activating antigen-presenting
cells to produce IL-6. Importantly, TGF-b
significantly suppressed Th22 cell
differentiation. Next, the authors per-
formed adaptive transfer experiments by
using in vitro differentiated Th17 cells
(induced by IL-6 + TGF-b) or Th22 cells
(induced by IL-6 alone) into Il22/ mice.
Transfer of Th22 cells rescued the recip-
ient Il22/ mice from C. rodentium
pathology, whereas Th17 cells had only
a modest effect. Collectively, these
results indicate that Th22 cells induced
by IL-6 play a critical role in the host
response against C. rodentium and
that in this adaptive phase, IL-23 is not
essential but enhances the action of IL-6
(Figure 1).
By transcriptome analysis, Basu et al.
(2012) identified T-bet as a transcription
factor that is expressed at significantly
higher levels by in vitro differentiated
Th22 versus Th17 cells. Mutation of
the T-bet gene (Tbx21) resulted in
compromised production of IL-22 by
T cells cultured under Th22 cell-inducing
conditions. Furthermore, when Tbx21/
mice were infected with C. rodentium,
their bacterial loads were significantly
greater than in wild-type mice during the
adaptive phase of the response, and
Tbx21/ T cells displayed significantly
lower IL-22 production. Therefore, T-bet
is required for the expression of IL-22 by
Th22 cells. In addition to T-bet, the aryl
hydrocarbon receptor (AhR) was shown
to regulate IL-22 expression by Th22
cells, despite its low-level expression by
these cells.ecember 14, 2012 ª2012 Elsevier Inc. 953
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PreviewsA T cell subset referred to as Th22 cell
has been described mainly in humans
(Duhen et al., 2009; Volpe et al., 2009),
and the existence of Th22 cells in mice
has been controversial. Human CD4+
Th22 cells have been detected in inflamed
and diseased skin in vivo and can be
induced from naive T cells after T cell
receptor stimulation in the presence
of IL-6 and TNF in vitro. Furthermore,
IL-22 expression by human CD4+ T cells
correlates better with expression of
the Th1 cell subset markers IFN-g and
T-bet than with expression of the Th17
cell subset marker IL-17A (Duhen et al.,
2009; Volpe et al., 2009). Th22 cells
described by Basu et al. (2012) have
similar characteristics to human Th22
cells and fit the criteria to be Th22 cells.
However, it is still unclear whether or not
Th17 and Th22 cell subsets, particularly
observed in pathogen-infected mice, are
truly distinct or represent activation
stages of a single plastic lineage modu-
lated by environmental cues. To define
Th22 cells as a unique population distinct
from Th17 cells, identification of a mole-
cule(s) that acts as a master regulator of954 Immunity 37, December 14, 2012 ª2012Th22 cell development and function, in
addition to T-bet and AhR, or a more
detailed cellular characterization will be
required. Another question this study
raises is the functional specificity of
Th22 cells, in other words, the qualitative
difference among Th22 cells, IL-22+
ILC3s, and Th17 cells. It has been re-
ported that IL-22+ ILC3s expand until
day 6 of C. rodentium infection but that
their number declines thereafter (Sonnen-
berg et al., 2011); therefore, activated
IL-22+ ILC3s may persist for a shorter
period compared to activated Th22
cells. This difference in turnover may be
a reason why adaptive Th22 cells are
required for clearance of this pathogen.
Further studies are required to completely
reveal the specific functions of Th22
cells during health and disease.
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Lymph nodes are compartmentalized organs but whether this feature has a role in T cell differentiation has
been unclear. In this issue, Groom et al. (2012) reveal that spatially separated expression of two CXCR3
ligands guides Th1 cell development.Generation of correctly polarized CD4+
T cell subsets is critical for successful
immune responses. Yet the complete set
of requirements for induction of effector
T cells within responding lymph nodes
(LNs) is not known. Subset-specific che-
mokine receptors have well-established
roles in guiding effector T cells to periph-eral tissues, but whether these receptors
influence early T cell differentiation events
has been less clear. In this issue, Groom
et al. (2012) show that the T helper 1
(Th1) cell-associated chemokine receptor
CXCR3 plays a crucial role in promoting
cell-cell interactions and guiding intra-
lymph node movements of activatedT cells that favor differentiation toward
an interferon-g (IFN-g)-producing Th1
cell phenotype (Groom et al., 2012). This
movement depends on expression of
two CXCR3 ligands in distinct LN
compartments.
CXCR3 has three ligands: CXCL9,
CXCL10, and CXCL11. Their original
